Navigation Links
Delivering siRNAs to Difficult Cell Types

y efficient method for transfecting primary and hard-to-transfect cells with siRNAs. This was demonstrated here using five different cell types. The results show that transfection via electroporation provides an efficient nonviral method to induce RNAi in cells that are resistant to siRNA delivery using chemical transfection agents. However, conditions vary with cell type and it is important to optimize siRNA concentration and pulse number to achieve optimal silencing. Delivery of siRNA to primary cell types, a setting where genetic manipulations have traditionally proved difficult, will be a valuable research tool in various applications including gene function analysis, target validation, gene discovery, and even development of gene-specific siRNA-based therapeutics.


Cy is a trademark of Amersham Biosciences.


back to top


Ordering Information
Cat# Product Name Size 8990 siPORT siRNA Electroporation Buffer 12 x 1.5 ml
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Delivering siRNA Using Adenoviral Vectors
2. Silencer Validated siRNAs
3. Cenix-Designed siRNAs for 95% of Human and Mouse Genomes
4. Five Ways to Produce siRNAs
5. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
6. IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!
7. Optimizing Chemical Transfection and Electroporation of siRNAs
8. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
9. Deliver siRNAs Into Primary Cells
10. Optimize Transfection of siRNAs for RNAi
11. RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Delivering siRNAs Difficult Cell Types

(Date:11/5/2009)...BURG, Md., Nov. 5 GenVec...ial results for the third quarter ended September ...on ($0.04 per share) for the three months ended Se...llion ($0.08 per share) in the comparable quarter ...009, GenVec,s net loss was $14.1 million ($0.15 pe...
(Date:11/5/2009)...ce Call on Thursday, November 5, 2009 at 4:30 p.m..... 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuti... OGXI ) today reported unaudited financial result...ember 30, 2009 and reviewed the Company,s highligh...ing consolidated results reflect the operations of...
(Date:11/5/2009)...O, CA, November 5, 2009 ...on using proprietary taste receptor-based technolo...food, beverage, and ingredient supply industries, ...ancial results for the third quarter ended Septemb...hird quarter of 2009, compared to $4.0 million for...
(Date:11/5/2009)... LASIK Surgery and vision correction ex...ry were actively involved at the recently conclude...ual Meeting in San Francisco, California. Dr. Step...Jonathan Davidorf, MD, Dr. Peter Rapoza, MD, Dr. M... Wayne Bowman, MD, Dr. Edward Manche, MD, and Dr. ...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
... Quality has been chosen to lead an effort to rep...ngs, but participation will not necessarily be bas...will be part of a federal pilot project to develop... from physician practices and present it in a form.... While the vision for this information exchange w...
...O Symposium , WTN caught up with Tom Koulopoulos f...,s a good idea. Read part one . , , WTN: You have... the risk of development to other organizations. B...h the loss of control? , , Koulopoulos Koulopo...cern is giving up control. We did some survey work...
...ected with the H5N1 avian influenza virus, mostly ... that the virus does not spread easily from its pi...omedical puzzle. , ,Now, a study of cells in the h... difference in the cells of the system that makes ...uman. , ,The finding, reported today (March 22) in...
Other Biology Technology:Healthcare quality initiative shuns high-tech for now 2IT outsourcing according to Tom Koulopoulos, part 2 2IT outsourcing according to Tom Koulopoulos, part 2 3IT outsourcing according to Tom Koulopoulos, part 2 4UW shows why avian flu hasn't spread among humans yet 2UW shows why avian flu hasn't spread among humans yet 3
(Date:11/4/2009)...ctant to officially endorse green tea as a cancer ...t its protective effects, including results of a n..., a journal of the American Association for Cancer...ancer. , Vassiliki Papadimitrakopoulo, M.D., pr...Head and Neck Medical Oncology at the University o...
(Date:11/4/2009)...he DNA codes, or genomes, of the famed fugu (or pu...e 10K Project, an international effort to build an...species of animals for conducting comparative stud... , Participating in The Genome 10K project, desc...ue of the Journal of Heredity , are 70 leading sc...
(Date:11/4/2009)...rstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a leadin...software, today reported financial results for its...Michael Tzannes, Aware,s Chairman and Chief Execut... agreement to sell our DSL and home networking pro...company being spun out of Infineon. This transact...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Singapore scientists join international study of 10,000 vertebrates' genomes 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 1aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 2MediZine Named in Intellectual Property Lawsuit Filed by Marketing Technology Solutions 58292 1MediZine Named in Intellectual Property Lawsuit Filed by Marketing Technology Solutions 58292 2UCI researchers create new strategy for highly selective chemotherapy delivery 58290 1UCI researchers create new strategy for highly selective chemotherapy delivery 58290 2
... 26, 2009 / b3c newswire / - Cambridge Healthtech ...gress will be held May 27-29, 2009 at the Loews Ph...advance registration deadline for this event is Ap...ealthtech Institute,s Biomarker Series, The Biomar...ss.com ) is dedicated to all areas of biomarker re...
....--For the first time, MIT engineers and colleague... and subsequent migration of hundreds of millions ...cted using a novel imaging technique, "provides in...ecosystems that vast oceanic fish shoals inhabit,"... . , It also confirms theories about the behavior...
... a fast bite spelled doom for bony fishes during t...rding to a new study to be published March 31, 200...Sciences . , Today, those same features characte... billfishes, that are currently in decline and at ... author of the study and a graduate student in evo...
Other Biology News:CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 2CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 3CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 4CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 5Team IDs genesis of mass migrations 2Team IDs genesis of mass migrations 3Study unravels why certain fishes went extinct 65 million years ago 2Study unravels why certain fishes went extinct 65 million years ago 3
COX Chemiluminescence Assay Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-p70 S6 Kinase, phospho (Thr229) Polyclonal Antibody, Unconjugated from R&D Systems
Sheep Growth Hormone from Cell Sciences
Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Biology Products: